Literature DB >> 28912269

Glycoprotein A repetitions predominant (GARP) positively regulates transforming growth factor (TGF) β3 and is essential for mouse palatogenesis.

Bill X Wu1, Anqi Li1, Liming Lei2, Satoshi Kaneko2, Caroline Wallace1, Xue Li2, Zihai Li3,4.   

Abstract

Glycoprotein A repetitions predominant (GARP) (encoded by the Lrrc32 gene) plays important roles in cell-surface docking and activation of TGFβ. However, GARP's role in organ development in mammalian systems is unclear. To determine the function of GARP in vivo, we generated a GARP KO mouse model. Unexpectedly, the GARP KO mice died within 24 h after birth and exhibited defective palatogenesis without apparent abnormalities in other major organs. Furthermore, we observed decreased apoptosis and SMAD2 phosphorylation in the medial edge epithelial cells of the palatal shelf of GARP KO embryos at embryonic day 14.5 (E14.5), indicating a defect in the TGFβ signaling pathway in the GARP-null developing palates. Of note, the failure to develop the secondary palate and concurrent reduction of SMAD phosphorylation without other defects in GARP KO mice phenocopied TGFβ3 KO mice, although GARP has not been suggested previously to interact with TGFβ3. We found that GARP and TGFβ3 co-localize in medial edge epithelial cells at E14.5. In vitro studies confirmed that GARP and TGFβ3 directly interact and that GARP is indispensable for the surface expression of membrane-associated latent TGFβ3. Our findings indicate that GARP is essential for normal morphogenesis of the palate and demonstrate that GARP plays a crucial role in regulating TGFβ3 signaling during embryogenesis. In conclusion, we have uncovered a novel function of GARP in positively regulating TGFβ3 activation and function.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  GARP, palatogenesis; TGFβ; apoptosis; cell signaling; development; embryo

Mesh:

Substances:

Year:  2017        PMID: 28912269      PMCID: PMC5672034          DOI: 10.1074/jbc.M117.797613

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Transforming growth factor-beta3 regulates transdifferentiation of medial edge epithelium during palatal fusion and associated degradation of the basement membrane.

Authors:  V Kaartinen; X M Cui; N Heisterkamp; J Groffen; C F Shuler
Journal:  Dev Dyn       Date:  1997-07       Impact factor: 3.780

2.  Cutting Edge: Active TGF-β1 Released from GARP/TGF-β1 Complexes on the Surface of Stimulated Human B Lymphocytes Increases Class-Switch Recombination and Production of IgA.

Authors:  Olivier Dedobbeleer; Julie Stockis; Bas van der Woning; Pierre G Coulie; Sophie Lucas
Journal:  J Immunol       Date:  2017-06-12       Impact factor: 5.422

Review 3.  Role of GARP in the activation of latent TGF-β1.

Authors:  Julie Stockis; Olivier Dedobbeleer; Sophie Lucas
Journal:  Mol Biosyst       Date:  2017-09-26

4.  Overexpression of Smad2 in Tgf-beta3-null mutant mice rescues cleft palate.

Authors:  Xiao-Mei Cui; Nobuyuki Shiomi; Jucheng Chen; Takashi Saito; Tadashi Yamamoto; Yoshihiro Ito; Pablo Bringas; Yang Chai; Charles F Shuler
Journal:  Dev Biol       Date:  2005-02-01       Impact factor: 3.582

Review 5.  TGFbeta in Cancer.

Authors:  Joan Massagué
Journal:  Cell       Date:  2008-07-25       Impact factor: 41.582

6.  Development and application of fully functional epitope-tagged forms of transforming growth factor-beta.

Authors:  Lawrence A Wolfraim; Gonnie M Alkemade; Biju Alex; Shellyann Sharpe; W Tony Parks; John J Letterio
Journal:  J Immunol Methods       Date:  2002-08-01       Impact factor: 2.303

7.  Tgfb1 expressed in the Tgfb3 locus partially rescues the cleft palate phenotype of Tgfb3 null mutants.

Authors:  Liang-Tung Yang; Vesa Kaartinen
Journal:  Dev Biol       Date:  2007-10-29       Impact factor: 3.582

8.  Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction.

Authors:  V Kaartinen; J W Voncken; C Shuler; D Warburton; D Bu; N Heisterkamp; J Groffen
Journal:  Nat Genet       Date:  1995-12       Impact factor: 38.330

9.  TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes.

Authors:  L P Sanford; I Ormsby; A C Gittenberger-de Groot; H Sariola; R Friedman; G P Boivin; E L Cardell; T Doetschman
Journal:  Development       Date:  1997-07       Impact factor: 6.868

10.  Mesenchymal stromal cells express GARP/LRRC32 on their surface: effects on their biology and immunomodulatory capacity.

Authors:  Ana Belén Carrillo-Galvez; Marién Cobo; Sara Cuevas-Ocaña; Alejandra Gutiérrez-Guerrero; Almudena Sánchez-Gilabert; Pierpaolo Bongarzone; Angélica García-Pérez; Pilar Muñoz; Karim Benabdellah; Miguel G Toscano; Francisco Martín; Per Anderson
Journal:  Stem Cells       Date:  2015-01       Impact factor: 6.277

View more
  13 in total

1.  GARP Dampens Cancer Immunity by Sustaining Function and Accumulation of Regulatory T Cells in the Colon.

Authors:  Mohammad Salem; Caroline Wallace; Maria Velegraki; Anqi Li; Ephraim Ansa-Addo; Alessandra Metelli; Hyunwoo Kwon; Brian Riesenberg; Bill Wu; Yongliang Zhang; Silvia Guglietta; Shaoli Sun; Bei Liu; Zihai Li
Journal:  Cancer Res       Date:  2019-01-23       Impact factor: 12.701

2.  Homozygous stop-gain variant in LRRC32, encoding a TGFβ receptor, associated with cleft palate, proliferative retinopathy, and developmental delay.

Authors:  Tamar Harel; Ephrat Levy-Lahad; Muhannad Daana; Hadas Mechoulam; Smadar Horowitz-Cederboim; Michal Gur; Vardiella Meiner; Orly Elpeleg
Journal:  Eur J Hum Genet       Date:  2019-04-11       Impact factor: 4.246

3.  A Milieu Molecule for TGF-β Required for Microglia Function in the Nervous System.

Authors:  Yan Qin; Brian S Garrison; Wenjiang Ma; Rui Wang; Aiping Jiang; Jing Li; Meeta Mistry; Roderick T Bronson; Daria Santoro; Charlotte Franco; Daisy A Robinton; Beth Stevens; Derrick J Rossi; Chafen Lu; Timothy A Springer
Journal:  Cell       Date:  2018-06-14       Impact factor: 41.582

4.  B lymphocytes confer immune tolerance via cell surface GARP-TGF-β complex.

Authors:  Caroline H Wallace; Bill X Wu; Mohammad Salem; Ephraim A Ansa-Addo; Alessandra Metelli; Shaoli Sun; Gary Gilkeson; Mark J Shlomchik; Bei Liu; Zihai Li
Journal:  JCI Insight       Date:  2018-04-05

Review 5.  Intracellular and extracellular TGF-β signaling in cancer: some recent topics.

Authors:  Kohei Miyazono; Yoko Katsuno; Daizo Koinuma; Shogo Ehata; Masato Morikawa
Journal:  Front Med       Date:  2018-07-24       Impact factor: 4.592

Review 6.  Integrin-Mediated TGFβ Activation Modulates the Tumour Microenvironment.

Authors:  Nicholas F Brown; John F Marshall
Journal:  Cancers (Basel)       Date:  2019-08-21       Impact factor: 6.639

7.  GARP is a key molecule for mesenchymal stromal cell responses to TGF-β and fundamental to control mitochondrial ROS levels.

Authors:  Ana Belén Carrillo-Gálvez; Sheyla Gálvez-Peisl; Juan Elías González-Correa; Marina de Haro-Carrillo; Verónica Ayllón; Pedro Carmona-Sáez; Verónica Ramos-Mejía; Pablo Galindo-Moreno; Francisca E Cara; Sergio Granados-Principal; Pilar Muñoz; Francisco Martin; Per Anderson
Journal:  Stem Cells Transl Med       Date:  2020-02-19       Impact factor: 6.940

Review 8.  Inducers, Attractors and Modulators of CD4+ Treg Cells in Non-Small-Cell Lung Cancer.

Authors:  Mengxiao Xie; Jia Wei; Jian Xu
Journal:  Front Immunol       Date:  2020-04-28       Impact factor: 7.561

Review 9.  Immunoregulatory functions and the therapeutic implications of GARP-TGF-β in inflammation and cancer.

Authors:  Alessandra Metelli; Mohammad Salem; Caroline H Wallace; Bill X Wu; Anqi Li; Xue Li; Zihai Li
Journal:  J Hematol Oncol       Date:  2018-02-20       Impact factor: 17.388

10.  TGF-β3 reduces apoptosis in ischemia-induced adipose-derived stem cells by enhancing DNA repair.

Authors:  Fan Wu; Haiwen Ye; Junfeng Lin; Yaodong Xu; Zhuasong Zhang; Hao Xiong; Maojin Laing; Yiqing Zhen; Suijun Chen
Journal:  Exp Ther Med       Date:  2018-03-21       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.